Study of Using Intravenous High-Titred Hapatitis B Immunoglobulin to Prevent Post-transfused Hepatitis B
- VernacularTitle:静脉输注高效价乙型肝炎免疫球蛋白预防输血后乙型肝炎的研究
- Author:
Guiqin XIE
- Publication Type:Journal Article
- From:
Chinese Journal of Blood Transfusion
1988;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Using the intravenous hightitred hepatitis B immunoglobulin (HBIG) to prevent post-transfusion hepatitis B was reported. Of the 90 recipients, 50 cases were in the HBIG group and 40 cases were in the control group. All together 11 cases of HBV infection were found. There were 2 cases (4%) in the HBIG group and 9 cases (22.5%) were in the control group, with the difference between them being very significant (P
